Details of the Drug

General Information of Drug (ID: DM5ZVLB)

Drug Name
Ixazomib
Indication
Disease Entry ICD 11 Status REF
Multiple myeloma 2A83 Approved [1]
Affected Organisms
Humans and other mammals
ATC Code
L01XG03: Ixazomib
L01XG: Proteasome inhibitors
L01X: OTHER ANTINEOPLASTIC AGENTS
L01: ANTINEOPLASTIC AGENTS
L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Structure
3D MOL is unavailable 2D MOL
Chemical Identifiers
Formula
C14H19BCl2N2O4
Canonical SMILES
B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O
InChI
1S/C14H19BCl2N2O4/c1-8(2)5-12(15(22)23)19-13(20)7-18-14(21)10-6-9(16)3-4-11(10)17/h3-4,6,8,12,22-23H,5,7H2,1-2H3,(H,18,21)(H,19,20)/t12-/m0/s1
InChIKey
MXAYKZJJDUDWDS-LBPRGKRZSA-N
Cross-matching ID
PubChem CID
25183872
ChEBI ID
CHEBI:90942
CAS Number
1072833-77-2
UNII
71050168A2
DrugBank ID
DB09570
TTD ID
D0Y2SW
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2015